These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 28820943)
21. Salt-regulated reversible fibrillation of Mycobacterium tuberculosis isocitrate lyase: Concurrent restoration of structure and activity. Shukla H; Kumar R; Sonkar A; Mitra K; Akhtar MS; Tripathi T Int J Biol Macromol; 2017 Nov; 104(Pt A):89-96. PubMed ID: 28591590 [TBL] [Abstract][Full Text] [Related]
22. Alterations in conformational topology and interaction dynamics caused by L418A mutation leads to activity loss of Mycobacterium tuberculosis isocitrate lyase. Shukla H; Shukla R; Sonkar A; Tripathi T Biochem Biophys Res Commun; 2017 Aug; 490(2):276-282. PubMed ID: 28610921 [TBL] [Abstract][Full Text] [Related]
23. Heterogeneous multimeric structure of isocitrate lyase in complex with succinate and itaconate provides novel insights into its inhibitory mechanism. Kwon S; Chun HL; Ha HJ; Lee SY; Park HH PLoS One; 2021; 16(5):e0251067. PubMed ID: 33951112 [TBL] [Abstract][Full Text] [Related]
24. [Effects of isocitrate lyase from Mycobacterium tuberculosis on the survival of Mycobacterium smegmatis in macrophage and mechanism thereof]. Li JM; Wan LG; Zhu DY; Li N; He YL; Yang C Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):551-4. PubMed ID: 18649772 [TBL] [Abstract][Full Text] [Related]
25. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies. Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083 [TBL] [Abstract][Full Text] [Related]
26. A systems chemical biology study of malate synthase and isocitrate lyase inhibition in Mycobacterium tuberculosis during active and NRP growth. May EE; Leitão A; Tropsha A; Oprea TI Comput Biol Chem; 2013 Dec; 47():167-80. PubMed ID: 24121675 [TBL] [Abstract][Full Text] [Related]
27. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis. Höner Zu Bentrup K; Miczak A; Swenson DL; Russell DG J Bacteriol; 1999 Dec; 181(23):7161-7. PubMed ID: 10572116 [TBL] [Abstract][Full Text] [Related]
28. [Molecular cloning, expression, purification and properties of isocitrate lyase gene from Mycobacterium tuberculosis H37Rv]. Hao F; Pei XY; Zhang XL; Zhang SB; Lai XH; Wang HH Zhonghua Jie He He Hu Xi Za Zhi; 2005 Dec; 28(12):845-8. PubMed ID: 16409788 [TBL] [Abstract][Full Text] [Related]
29. Mycobacterium tuberculosis isocitrate lyase (MtbIcl): role of divalent cations in modulation of functional and structural properties. Kumar R; Bhakuni V Proteins; 2008 Aug; 72(3):892-900. PubMed ID: 18275086 [TBL] [Abstract][Full Text] [Related]
30. [Clone and expression of isocitrate lyase gene in Mycobacterium tuberculosis H37Rv]. Li DW; Xiao CL; Guan Y Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):368-71. PubMed ID: 15379258 [TBL] [Abstract][Full Text] [Related]
31. Biochemical properties and crystal structure of isocitrate lyase from Bacillus cereus ATCC 14579. Lee SH; Ki D; Kim S; Kim IK; Kim KJ Biochem Biophys Res Commun; 2020 Dec; 533(4):1177-1183. PubMed ID: 33041004 [TBL] [Abstract][Full Text] [Related]
33. Characterization of a bifunctional glyoxylate cycle enzyme, malate synthase/isocitrate lyase, of Euglena gracilis. Nakazawa M; Nishimura M; Inoue K; Ueda M; Inui H; Nakano Y; Miyatake K J Eukaryot Microbiol; 2011; 58(2):128-33. PubMed ID: 21332878 [TBL] [Abstract][Full Text] [Related]
34. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Muñoz-Elías EJ; McKinney JD Nat Med; 2005 Jun; 11(6):638-44. PubMed ID: 15895072 [TBL] [Abstract][Full Text] [Related]
35. DNAzymes targeting the icl gene inhibit ICL expression and decrease Mycobacterium tuberculosis survival in macrophages. Li J; Zhu D; Yi Z; He Y; Chun Y; Liu Y; Li N Oligonucleotides; 2005; 15(3):215-22. PubMed ID: 16201909 [TBL] [Abstract][Full Text] [Related]
36. Residues Asn214, Gln211, Glu219 and Gln221 contained in the subfamily 3 catalytic signature of the isocitrate lyase from Pseudomonas aeruginosa are involved in its catalytic and thermal properties. Campos-Garcia J; Diaz-Perez C; Diaz-Perez AL World J Microbiol Biotechnol; 2013 Jun; 29(6):991-9. PubMed ID: 23338961 [TBL] [Abstract][Full Text] [Related]
37. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nandakumar M; Nathan C; Rhee KY Nat Commun; 2014 Jun; 5():4306. PubMed ID: 24978671 [TBL] [Abstract][Full Text] [Related]
38. Probing the Catalytic Mechanism Involved in the Isocitrate Lyase Superfamily: Hybrid Quantum Mechanical/Molecular Mechanical Calculations on 2,3-Dimethylmalate Lyase. Jongkon N; Chotpatiwetchkul W; Gleeson MP J Phys Chem B; 2015 Sep; 119(35):11473-84. PubMed ID: 26224328 [TBL] [Abstract][Full Text] [Related]
39. Rv1915 and Rv1916 from Mycobacterium tuberculosis H37Rv form in vitro protein-protein complex. Antil M; Gupta V Biochim Biophys Acta Gen Subj; 2022 Jun; 1866(6):130130. PubMed ID: 35307510 [TBL] [Abstract][Full Text] [Related]
40. Cysteine is the general base that serves in catalysis by isocitrate lyase and in mechanism-based inhibition by 3-nitropropionate. Moynihan MM; Murkin AS Biochemistry; 2014 Jan; 53(1):178-87. PubMed ID: 24354272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]